Repligen (RGEN) Gains from Investment Securities (2013 - 2026)
Repligen's (RGEN) quarterly Gains from Investment Securities came in at -$146000.0 in Q1 2026, up 90.39% on a QoQ basis from -$1.5 million in Q4 2025.
Repligen (RGEN) Gains from Investment Securities (2013 - 2026) Analysis & Trends
Repligen (RGEN) has 9 years of Gains from Investment Securities data on file, last reported at -$146000.0 in Q1 2026.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$146000.0 in Q1 2026; TTM through Mar 2026 was -$13.8 million, a 530.99% decrease from a year earlier, with the FY2025 full-year figure at -$13.6 million, down 526.42% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$146000.0, up from -$1.5 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for RGEN reached as high as $3.2 million in Q4 2024 and fell as low as -$34.3 million in Q3 2023.
- Historically, Gains from Investment Securities has averaged -$5.4 million across 5 years, with a median of -$2.3 million in 2022.
- Across the five-year window, Gains from Investment Securities tumbled 1385.15% in 2023 and jumped 357.82% in 2024, its largest moves.
- Year by year, Gains from Investment Securities stood at -$17.1 million in 2022, then jumped by 104.07% to $697000.0 in 2023, then soared by 357.82% to $3.2 million in 2024, then slumped by 147.63% to -$1.5 million in 2025, then surged by 90.39% to -$146000.0 in 2026.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were -$146000.0 in Q1 2026, -$1.5 million in Q4 2025, and -$4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Repligen | 7.37 Bn | 6.39 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146,000.00 |
| Mar 31, 2026 | -146,000.00 |
| Dec 31, 2025 | -1.52 Mn |
| Dec 31, 2025 | -1.52 Mn |
| Sep 30, 2025 | -4.15 Mn |
| Sep 30, 2025 | -4.15 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 697,000.00 |
| Dec 31, 2023 | 697,000.00 |
| Sep 30, 2023 | -34.29 Mn |
| Sep 30, 2023 | -34.29 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | -17.13 Mn |
| Dec 31, 2022 | -17.13 Mn |